Alex John Ntamatungiro

In the News

Malaria: Call for action to curb insecticide resistance

Ifakara Health Institute (IHI) scientist Gerry Killeen has called for the international community to be bolder in adopting new products for existing interventions such as insecticide treated bed nets, so …

Muhas don is new IHI board member

Prof. Kaaya. Ifakara Health Institute (IHI) Board of Governors (BOG) has appointed Prof. Sylvia Kaaya member of the IHI Board of Trustees (BOT) effective Wednesday January 10, 2018. The appointment …

Recent Projects

Development of a new tool for malaria mosquito surveillance to improve vector control

Malaria transmission is influenced not only by vector abundance, but as well by demographic traits such as vector species and age structure, as these influence the intensity by which the …

Demonstrating complete disruption of residual malaria transmission by eliminating Anopheles funestus mosquitoes from rural Tanzanian villages

In rural south-eastern Tanzania, where malaria prevalence has reduced by >60% since 2000, low-to-moderate transmission still persists despite very high coverage with long-lasting insecticidal bednets. Like in most residual transmission …

Alex John Ntamatungiro

Research Scientist

He is a molecular biologist. His research focus is on molecular biology of infectious disease. Alex currently works at the Chronic Diseases Clinic-Ifakara (CDCI). His current research is on HIV-drug resistance dynamics. His routine work involves; PCR test for HIV Early Infants Diagnosis, HIV-viral load measurements and Genetic sequencing for HIV-drug resistance mutations analysis. His previous research was supported by research grants from Wellcome-Trust and Grand Challenge Canada. Alex was himself a Wellcome Trust Masters Research Fellow until 2014, during which time he worked on sub-microscopic malaria infections, before eventually joining the HIV team.

 View Alex’s Research Interests and Publications


Kilombero and Ulanga antiretroviral cohort study (KIULARCO)

Epidemiology and molecular monitoring of HIV drug resistance in Tanzania

© Ifakara Health Institute (IHI), 2016